Total Payments
$380.47
2024 Payments
$23.96
Companies
6
Transactions
12
Medicare Patients
1,830
Medicare Billing
$213,132
Payment Breakdown by Category
Food & Beverage$208.52 (54.8%)
Education$171.95 (45.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $208.52 | 10 | 54.8% |
| Education | $171.95 | 2 | 45.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $106.92 | 2 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $96.50 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $64.47 | 3 | $0 (2023) |
| Insmed, Inc. | $57.97 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $42.79 | 2 | $0 (2023) |
| GENZYME CORPORATION | $11.82 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.96 | 1 | Insmed, Inc. ($23.96) |
| 2023 | $58.56 | 3 | AstraZeneca Pharmaceuticals LP ($22.86) |
| 2022 | $236.25 | 5 | Regeneron Healthcare Solutions, Inc. ($106.92) |
| 2021 | $13.19 | 1 | Insmed, Inc. ($13.19) |
| 2019 | $20.60 | 1 | AstraZeneca Pharmaceuticals LP ($20.60) |
| 2018 | $27.91 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($27.91) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/11/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Respiratory | ||||||
| 07/26/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Respiratory | ||||||
| 04/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Respiratory | ||||||
| 11/11/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Immunology | ||||||
| 10/13/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/12/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Respiratory | ||||||
| 06/14/2022 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $96.50 | General |
| Category: Immunology | ||||||
| 06/13/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $75.45 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/20/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Respiratory | ||||||
| 11/15/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Respiratory | ||||||
| 09/01/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 511 | 644 | $174,406 | $49,536 |
| 2022 | 12 | 410 | 543 | $155,438 | $44,482 |
| 2021 | 14 | 537 | 739 | $197,833 | $65,938 |
| 2020 | 11 | 372 | 599 | $174,601 | $53,176 |
Total Patients
1,830
Total Services
2,525
Medicare Billing
$213,132
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 264 | $96,672 | $27,283 | 28.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 13 | 39 | $23,961 | $6,937 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $24,396 | $6,759 | 27.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 25 | 25 | $9,118 | $2,551 | 28.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 53 | 53 | $5,117 | $1,488 | 29.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 14 | 14 | $2,884 | $1,061 | 36.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 13 | $3,374 | $988.05 | 29.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 38 | 38 | $3,584 | $918.88 | 25.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $1,218 | $472.50 | 38.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 47 | 47 | $1,598 | $440.61 | 27.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 47 | 47 | $1,197 | $326.92 | 27.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 39 | 39 | $1,287 | $309.47 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 135 | 235 | $85,660 | $24,109 | 28.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 15 | 32 | $19,680 | $5,853 | 29.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $15,169 | $4,215 | 27.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 28 | 34 | $12,414 | $3,589 | 28.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $6,681 | $1,983 | 29.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 44 | 45 | $4,296 | $1,272 | 29.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 14 | $4,032 | $1,210 | 30.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 31 | 34 | $2,224 | $858.24 | 38.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 32 | 33 | $3,069 | $776.71 | 25.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 25 | 26 | $884.00 | $254.15 | 28.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 26 | 27 | $702.00 | $196.01 | 27.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 19 | 19 | $627.00 | $165.44 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 140 | 266 | $79,002 | $29,649 | 37.5% |
About Dr. Frederick Troncales, M.D
Dr. Frederick Troncales, M.D is a Pulmonary Disease healthcare provider based in Burien, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851484398.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frederick Troncales, M.D has received a total of $380.47 in payments from pharmaceutical and medical device companies, with $23.96 received in 2024. These payments were reported across 12 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($208.52).
As a Medicare-enrolled provider, Troncales has provided services to 1,830 Medicare beneficiaries, totaling 2,525 services with total Medicare billing of $213,132. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine, Critical Care Medicine
- Location Burien, WA
- Active Since 10/02/2006
- Last Updated 01/18/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1851484398
Products in Payments
- DUPIXENT (Biological) $215.24
- Arikayce (Drug) $57.97
- JARDIANCE (Drug) $27.91
- BREZTRI (Drug) $22.86
- FASENRA (Biological) $21.01
- FASENRA (Drug) $20.60
- OFEV (Drug) $14.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.